What is the Anna Karenina Principle of Monetary Policy?
What is the Anna Karenina Principle of Monetary Policy?
Similar Posts
I got an unexpected $1,000 medical bill. Here’s why I’m not paying it yet.
Before you pay any medical bill, take these steps to check it — and possibly lower it.
Optimal Flood Insurance in a Second-Best World: Fiscal Spillovers, Reclassification Risk and Moral Hazard — by Jonathan Gruber, Adam Solomon
Intensifying climate change makes protection against natural disaster risk – either through ex ante insurance or ex post aid – a first-order public policy issue. Flood risk protection in the U.S. traditionally featured ex post aid through FEMA and heavily subsidized insurance through the National Flood Insurance Program (NFIP). In an effort to correct subsidy-induced…
The Japanese Yen has a second buyer nobody will name
Thursday’s record Yen defence is the story everyone has written. Friday is the one that matters, because the Dollar has been sold in three separate lurches since the Tokyo morning, nobody has claimed any of them, and the US Treasury has told a number of banks through the New York Fed that it may enter…
US Bonus Depreciation: Tax Policy OECD Countries Should Copy
Canada and Germany should follow suit, making immediate deductions for machinery and equipment investment permanent to strengthen their business investment climate. Capital investment is critical for driving innovation and sustainable economic growth. Unfortunately, some countries’ important investment incentives are scheduled to decrease in the coming years—including in three countries that account for nearly a fifth…
Alphabet Just Tied Amazon’s $200 Billion Capex Guidance. Could Amazon Raise the Bar Even Higher on July 30?
Big tech companies and spending on artificial intelligence and its infrastructure have been one of the biggest stories in the stock market this year, ever since Amazon (AMZN -4.50%), Alphabet (GOOG -6.86%) (GOOGL -7.02%), Microsoft, and Meta Platforms disclosed plans to spend $700 billion on capital expenditures this year. Of that, Amazon was the biggest…
Novo Nordisk sued by shareholders over weight-loss drug: What to know
Novo Nordisk shareholders are suing the drugmaker over its experimental obesity treatment CagriSema, alleging the company misled investors about a key clinical trial before releasing disappointing results that wiped billions of dollars off its market value. A federal judge on Tuesday allowed parts of that lawsuit to move forward, finding that investors had plausibly alleged…
